Skip to main content
Clinical Trials/NCT04576663
NCT04576663
Not yet recruiting
Not Applicable

Phenylephrine Prophylaxis for Postspinal Anesthesia Hypotension in Parturients With Preeclampsia Undergoing Cesarean Section: a Randomized, Placebo-controlled Dose-finding Trial

General Hospital of Ningxia Medical University0 sites95 target enrollmentOctober 1, 2023

Overview

Phase
Not Applicable
Intervention
Phenylephrine
Conditions
Adverse Effect
Sponsor
General Hospital of Ningxia Medical University
Enrollment
95
Primary Endpoint
The incidence of post-spinal anesthesia hypotension
Status
Not yet recruiting
Last Updated
4 years ago

Overview

Brief Summary

The purpose of this study is to investigate the suitable infusion dose of phenylephrine for prophylaxis against postspinal anesthesia hypotension in parturients with preeclampsia undergoing cesarean section.

Detailed Description

Preeclampsia, which affects 5% to 7% of parturients, is a significant cause of maternal and neonatal morbidity and mortality. Because of constricted myometrial spiral arteries with exaggerated vasomotor responsiveness, though blood pressure in parturients with preeclampsia are apparently higher than healthy parturients, placental hypoperfusion is more common. Spinal anesthesia is still the preferred mode of anesthesia in parturients with preeclampsia for cesarean section. In preeclampsia parturients, spinal anesthesia improve intervillous blood flow (provided that hypotension is avoided) which contribute to increase placental perfusion. Even so, 17-26% parturients with preeclampsia experienced postspinal anesthesia hypotension due to the extensive sympathetic block that occurred with spinal anesthesia. Practical guidelines for obstetric anesthesia from the American Society of Anesthesiologists and an international consensus statement on the management of hypotension with vasopressors indicate either IV ephedrine or phenylephrine may be used to correct hypotension. But the suitable infusion dose of phenylephrine in parturients with preeclampsia is still unknown. The purpose of this study is to investigate the suitable infusion dose of phenylephrine for prophylaxis against post-spinal anesthesia hypotension in parturients with preeclampsia undergoing cesarean section.

Registry
clinicaltrials.gov
Start Date
October 1, 2023
End Date
September 21, 2025
Last Updated
4 years ago
Study Type
Interventional
Study Design
Parallel
Sex
Female

Investigators

Sponsor
General Hospital of Ningxia Medical University
Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • 18-45 years
  • Primipara or multipara
  • Singleton pregnancy ≥32 weeks
  • American Society of Anesthesiologists physical status classification II to III
  • Scheduled for cesarean section under spinal anesthesia

Exclusion Criteria

  • Baseline blood pressure ≥180 mmHg
  • Body height \< 150 cm
  • Body weight \> 100 kg or body mass index (BMI) ≥ 40 kg/m2
  • Eclampsia or chronic hypertension
  • Hemoglobin \< 7g/dl
  • Fetal distress, or known fetal developmental anomaly

Arms & Interventions

0.625 μg/kg/min group

A maintenance dose of phenylephrine (0.625 μg/kg/ min) infusion simultaneous with subarachnoid block

Intervention: Phenylephrine

Control group

Normal saline infusion simultaneous with subarachnoid block

Intervention: Normal saline

0.3125 μg/kg/min group

A maintenance dose of phenylephrine (0.3125 μg/kg/ min) infusion simultaneous with subarachnoid block

Intervention: Phenylephrine

0.9375 μg/kg/min group

A maintenance dose of phenylephrine (0.9375 μg/kg/ min) infusion simultaneous with subarachnoid block

Intervention: Phenylephrine

Outcomes

Primary Outcomes

The incidence of post-spinal anesthesia hypotension

Time Frame: 1-15 minutes after spinal anesthesia

Systolic blood pressure (SBP) \< 80% of the baseline

Secondary Outcomes

  • Overall stability of heart rate control versus baseline(1-15 minutes after spinal anesthesia)
  • APGAR score(5 min after delivery)
  • The incidence of hypertension.(1-15 minutes after spinal anesthesia)
  • pH(Immediately after delivery)
  • Partial pressure of oxygen(Immediately after delivery)
  • Base excess(Immediately after delivery)
  • Overall stability of systolic blood pressure control versus baseline(1-15 minutes after spinal anesthesia)
  • The incidence of severe post-spinal anesthesia hypotension(1-15 minutes after spinal anesthesia)
  • The incidence of nausea and vomiting(1-15 minutes after spinal anesthesia)
  • The incidence of bradycardia(1-15 minutes after spinal anesthesia)

Similar Trials